We believe novel technologies like machine learning, synthetic biology and genomic sequencing will trigger a step-change in healthcare. At GenomeKey, we have assembled a team with the skills to drive this progress forward, to a place where the guesswork is removed from the diagnostic process. We are building a future where data driven diagnostics enable tailored, effective medical treatments.
Sepsis now kills more people than cancer. It can hit anyone, of any age, and kills within hours. And yet, if you or I were admitted to a hospital today, we would wait 3 days before the doctor knows which antibiotic will fight our infection. This is not good enough.
GenomeKey uses cutting edge machine learning and DNA sequencing to bring 3 days down to just a few hours. This saves lives, saves money, and saves our last antibiotics for when we really need them.
Sepsis directly costs the NHS two billion pounds every year. We have raised grant funding and a seed investment to bring our test through development, which will be the only affordable test that provides a result for every patient. If you are as passionate about this as we are, get in touch. Together we can win the fight against Sepsis.
We have assembled a team of talented and motivated people to drive forward the technology and innovation required. Pulling together experience from a wide range of industries, academic institutes and backgrounds, we believe we have what it takes to make a step-change improvement and redesign the world of Sepsis diagnostics.
Dr Michael Roberts
Director
CEO
Dr Daniel Rogerson
Director
CSO
Chris Heys
Director
CTO
Ben Leach
Director
CISO
Shelley Leggett
Office Administrator
Dr Clio Andreae
Senior Scientist
Dr Josh Dyer
Scientist
Dr Sarah Palmer
Scientist
Dr Scott McCormick
Microfluidics Engineer
Ben Noordijk
Bioinformatics Intern
Roddy McNeill
Machine Learning Engineer
Réka Hagymási
Machine Learning Engineer